logo
搜索
菜单

的搜索结果

当前1080/1088页
排序: 总浏览数
14.8: Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase 01:11 min
14.8: Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
13.15: iChip 01:24 min
13.15: iChip
10.4: The Winogradsky Column 01:27 min
10.4: The Winogradsky Column
Investigating the Human Gut Microbial Activity on Exopolysaccharides 02:46 min
Investigating the Human Gut Microbial Activity on Exopolysaccharides
Detection of Human Fecal Metabolites Using a Bacterial Biosensor 01:18 min
Detection of Human Fecal Metabolites Using a Bacterial Biosensor
13.13: Production of Pharmaceuticals 01:30 min
13.13: Production of Pharmaceuticals
13.2: Bioreactor Controls-I 01:28 min
13.2: Bioreactor Controls-I
18.5: Antifungal Agents 01:15 min
18.5: Antifungal Agents
14.11: Gut-Brain Axis 01:22 min
14.11: Gut-Brain Axis
11.2: Microbial Bioremediation of Hydrocarbons 01:26 min
11.2: Microbial Bioremediation of Hydrocarbons
11.6: Imperfections in Crystal Structure: Stoichiometric Point Defects 01:26 min
11.6: Imperfections in Crystal Structure: Stoichiometric Point Defects
5.7: The Clausius–Clapeyron Equation 01:29 min
5.7: The Clausius–Clapeyron Equation
13.16: Vaccine Production 01:23 min
13.16: Vaccine Production
Establishing a Mouse Model of Vaginal Group B Streptococcus Infection 03:42 min
Establishing a Mouse Model of Vaginal Group B Streptococcus Infection
4.2: Ideal Solutions or Mixtures 01:20 min
4.2: Ideal Solutions or Mixtures
13.14: Production of Biopesticides 01:18 min
13.14: Production of Biopesticides
15.13: Pharmacodynamic Models: Additive and Proportional Drug Effect Model 01:09 min
15.13: Pharmacodynamic Models: Additive and Proportional Drug Effect Model
8.4: Conductometric Titrations: Strong Acid-Base and Weak Acid-Base Titrations 01:29 min
8.4: Conductometric Titrations: Strong Acid-Base and Weak Acid-Base Titrations
6.5: Colligative Properties 01:18 min
6.5: Colligative Properties
6.3: Liquid–Solid Solutions 01:29 min
6.3: Liquid–Solid Solutions
返回顶部